Personalis, Inc. Selling, General and Administrative Expense
Personalis, Inc. (PSNL) reported Selling, General and Administrative Expense of $22.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-04
- Personalis, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $22.00M, a 55.14% increase year-over-year.
- Personalis, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $17.90M, a 45.99% increase year-over-year.
- Personalis, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $14.09M, a 26.20% increase year-over-year.
- Personalis, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $13.03M, a 13.89% increase year-over-year.
- Personalis, Inc. selling, general and administrative expense for fiscal 2025 was $53.57M, a 15.99% increase from fiscal 2024.
- Personalis, Inc. selling, general and administrative expense for fiscal 2024 was $46.19M, a 7.12% decline from fiscal 2023.
- Personalis, Inc. selling, general and administrative expense for fiscal 2023 was $49.73M, a 22.27% decline from fiscal 2022.
- Personalis, Inc. selling, general and administrative expense for fiscal 2022 was $63.97M, a 34.11% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.00M 10-Q · filed 2026-08-04 | $39.90M 10-Q · filed 2026-08-04 | $53.99M derived: sum of 3 quarters · filed 2026-08-04 | $67.03M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $17.90M 10-Q · filed 2026-05-07 | $32.00M derived: sum of 2 quarters · filed 2026-05-07 | $45.03M derived: sum of 3 quarters · filed 2026-05-07 | $59.21M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $14.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $27.13M derived: sum of 2 quarters · filed 2026-02-26 | $41.31M derived: sum of 3 quarters · filed 2026-08-04 | $53.57M 10-K · filed 2026-02-26 |
| 2025-09-30 | $13.03M 10-Q · filed 2025-11-04 | $27.21M derived: sum of 2 quarters · filed 2026-08-04 | $39.48M 10-Q · filed 2025-11-04 | $50.64M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $14.18M 10-Q · filed 2026-08-04 | $26.44M 10-Q · filed 2026-08-04 | $37.61M derived: sum of 3 quarters · filed 2026-08-04 | $49.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $12.26M 10-Q · filed 2026-05-07 | $23.43M derived: sum of 2 quarters · filed 2026-05-07 | $34.88M derived: sum of 3 quarters · filed 2026-05-07 | $46.85M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $11.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.61M derived: sum of 2 quarters · filed 2026-02-26 | $34.59M derived: sum of 3 quarters · filed 2026-02-26 | $46.19M 10-K · filed 2026-02-26 |
| 2024-09-30 | $11.44M 10-Q · filed 2025-11-04 | $23.42M derived: sum of 2 quarters · filed 2025-11-04 | $35.02M 10-Q · filed 2025-11-04 | $46.54M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $11.97M 10-Q · filed 2025-08-05 | $23.57M 10-Q · filed 2025-08-05 | $35.10M derived: sum of 3 quarters · filed 2025-08-05 | $47.07M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $11.60M 10-Q · filed 2025-05-06 | $23.13M derived: sum of 2 quarters · filed 2025-05-06 | $35.10M derived: sum of 3 quarters · filed 2025-05-06 | $47.23M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $11.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $23.50M derived: sum of 2 quarters · filed 2025-02-27 | $35.63M derived: sum of 3 quarters · filed 2025-02-27 | $49.73M 10-K · filed 2025-02-27 |
| 2023-09-30 | $11.97M 10-Q · filed 2024-11-06 | $24.11M derived: sum of 2 quarters · filed 2024-11-06 | $38.20M 10-Q · filed 2024-11-06 | $56.03M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $12.13M 10-Q · filed 2024-08-07 | $26.23M 10-Q · filed 2024-08-07 | $44.06M derived: sum of 3 quarters · filed 2024-08-07 | $58.84M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $14.10M 10-Q · filed 2024-05-08 | $31.93M derived: sum of 2 quarters · filed 2024-05-08 | $46.71M derived: sum of 3 quarters · filed 2024-05-08 | $62.58M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $17.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $32.61M derived: sum of 2 quarters · filed 2024-02-28 | $48.48M derived: sum of 3 quarters · filed 2024-02-28 | $63.97M 10-K · filed 2024-02-28 |
| 2022-09-30 | $14.78M 10-Q · filed 2023-11-07 | $30.66M derived: sum of 2 quarters · filed 2023-11-07 | $46.14M 10-Q · filed 2023-11-07 | $59.85M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $15.87M 10-Q · filed 2023-08-08 | $31.36M 10-Q · filed 2023-08-08 | $45.07M derived: sum of 3 quarters · filed 2024-02-28 | $57.21M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $15.49M 10-Q · filed 2023-05-03 | $29.20M derived: sum of 2 quarters · filed 2024-02-28 | $41.34M derived: sum of 3 quarters · filed 2024-02-28 | $52.76M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $13.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $25.85M derived: sum of 2 quarters · filed 2024-02-28 | $37.28M derived: sum of 3 quarters · filed 2024-02-28 | $47.70M 10-K · filed 2024-02-28 |
| 2021-09-30 | $12.14M 10-Q · filed 2022-11-02 | $23.57M derived: sum of 2 quarters · filed 2022-11-02 | $33.99M 10-Q · filed 2022-11-02 | $44.91M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $11.43M 10-Q · filed 2022-08-03 | $21.85M 10-Q · filed 2022-08-03 | $32.77M derived: sum of 3 quarters · filed 2023-02-23 | $40.56M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $10.42M 10-Q · filed 2022-05-04 | $21.34M derived: sum of 2 quarters · filed 2023-02-23 | $29.13M derived: sum of 3 quarters · filed 2023-02-23 | $36.84M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $10.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $18.71M derived: sum of 2 quarters · filed 2023-02-23 | $26.42M derived: sum of 3 quarters · filed 2023-02-23 | $33.69M 10-K · filed 2023-02-23 |
| 2020-09-30 | $7.79M 10-Q · filed 2021-11-04 | $15.50M derived: sum of 2 quarters · filed 2021-11-04 | $22.77M 10-Q · filed 2021-11-04 | $29.16M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $7.71M 10-Q · filed 2021-08-04 | $14.98M 10-Q · filed 2021-08-04 | $21.37M derived: sum of 3 quarters · filed 2022-02-24 | $27.42M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $7.27M 10-Q · filed 2021-05-05 | $13.66M derived: sum of 2 quarters · filed 2022-02-24 | $19.72M derived: sum of 3 quarters · filed 2022-02-24 | $25.18M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $6.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $12.44M derived: sum of 2 quarters · filed 2022-02-24 | $17.91M derived: sum of 3 quarters · filed 2022-02-24 | $22.08M 10-K · filed 2022-02-24 |
| 2019-09-30 | $6.06M 10-Q · filed 2020-11-05 | $11.52M derived: sum of 2 quarters · filed 2020-11-05 | $15.69M 10-Q · filed 2020-11-05 | $19.39M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $5.47M 10-Q · filed 2020-08-06 | $9.64M 10-Q · filed 2020-08-06 | $13.33M derived: sum of 3 quarters · filed 2021-02-25 | $15.99M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $4.17M 10-Q · filed 2020-05-07 | $7.87M derived: sum of 2 quarters · filed 2021-02-25 | $10.52M derived: sum of 3 quarters · filed 2021-02-25 | $13.13M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $6.35M derived: sum of 2 quarters · filed 2021-02-25 | $8.96M derived: sum of 3 quarters · filed 2021-02-25 | $11.27M 10-K · filed 2021-02-25 |
| 2018-09-30 | $2.66M 10-Q · filed 2019-11-13 | $5.26M derived: sum of 2 quarters · filed 2019-11-13 | $7.58M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $2.60M 10-Q · filed 2019-08-13 | $4.92M 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | $9.90M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |